Literature DB >> 4005143

Immunoreactive inhibin-like material in serum and gastric juice of patients with benign and malignant diseases of the stomach.

S A Shanbhag, A R Sheth, S A Nanivadekar, N A Sheth.   

Abstract

Immunoreactive inhibin-like material (ILM) was measured by radioimmunoassay (RIA) in serum and gastric juice samples of 23 fasting normal men, 27 men with chronic superficial gastritis (CSG), and 21 men with carcinoma of stomach (5 for gastric analysis). Serum ILM levels in carcinoma of stomach patients (367 +/- 55.5 ng ml-1) were significantly higher than in normal men (15.4 +/- 2.6 ng ml-1; P less than 0.01) and in patients with CSG (109.8 +/- 17.7 ng ml-1; P less than 0.05). Sixty two per cent and 86% of patients with carcinoma of stomach showed elevated ILM levels which were higher than the highest noted in patients with CSG and normal men respectively.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4005143      PMCID： PMC1977073          DOI： 10.1038/bjc.1985.133

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  17 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Long-term follow-up of subjects with superficial gastritis or a normal gastric mucosa.

Authors:  M Siurala; H J Salmi
Journal:  Scand J Gastroenterol       Date:  1971       Impact factor: 2.423

3.  Biological studies with low and high molecular weight inhibin preparations.

Authors:  S Vijayalakshmi; P R Sheth; S P Dandekar; A Y Vaze; S B Moodbidri; A R Sheth
Journal:  Int J Androl       Date:  1981-12

4.  Characterization of a polypeptide from human seminal plasma with inhibin (inhibition of FSH secretion)-like activity.

Authors:  A R Sheth; N Arabatti; M Carlquist; H Jörnvall
Journal:  FEBS Lett       Date:  1984-01-02       Impact factor: 4.124

5.  Measurement of inhibin.

Authors:  S B Moodbidri; A Y Vaze; A R Sheth
Journal:  Arch Androl       Date:  1980-12

6.  Ectopic human placental lactogen and beta-human chorionic gonadotropin in gastric fluid of patients with malignant and non-malignant conditions of the stomach.

Authors:  S R Shinde; M A Adil; A R Sheth; M G Koppikar; N A Sheth
Journal:  Oncology       Date:  1981       Impact factor: 2.935

7.  A peptide in gastric secretion with inhibin-like properties.

Authors:  N A Sheth; A Y Vaze; A R Sheth
Journal:  Clin Endocrinol (Oxf)       Date:  1982-08       Impact factor: 3.478

8.  Pernicious anaemia as a risk factor in gastric cancer.

Authors:  L Elsborg; J Mosbech
Journal:  Acta Med Scand       Date:  1979

9.  Paraendocrine behaviour of tumours of the gastrointestinal tract with reference to human placental lactogen.

Authors:  N A Sheth; M A Adil; S R Shinde; A R Sheth
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

10.  Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here?

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640
View more
  3 in total

1.  Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis.

Authors:  Priyanka Singh; Laura M Jenkins; Ben Horst; Victoria Alers; Shrikant Pradhan; Prabhjot Kaur; Tapasya Srivastava; Nadine Hempel; Balázs Győrffy; Eugenia V Broude; Nam Y Lee; Karthikeyan Mythreye
Journal:  Cancer Res       Date:  2018-03-13       Impact factor: 12.701

2.  Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers.

Authors:  Shrikant Pradhan; Roohi Chaudhary; Ben Horst; Eduardo Listik; Liz Quintero-Macias; Alex Seok Choi; Michael Southard; Yingmiao Liu; Regina Whitaker; Nadine Hempel; Andrew Berchuck; Andrew B Nixon; Nam Y Lee; Yoav I Henis; Karthikeyan Mythreye
Journal:  Commun Biol       Date:  2022-06-02

3.  Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: comparison of its distribution in normal, benign and malignant prostates.

Authors:  V M Doctor; A R Sheth; M M Simha; N J Arbatti; J P Aaveri; N A Sheth
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.